Abstract
Four indoleamine antagonists were evaluated for relative potencies as inhibitors of tryptamine-induced forepaw clonus and 5-hydroxytryptophan-evoked head twitches. Methergoline was approximately three times more potent against the forepaw clonus than the head twitch response, whereas methysergide exhibited nearly equal activity in both tests. Cyproheptadine and cinanserin showed a profile opposite to methergoline and a greater degree of selectivity, being 25 to 40 times more potent as inhibitors of the 5-hydroxytryptophan- than of the tryptamine-induced response. These findings clearly demonstrate that the rank order of potency of indoleamine antagonists varies greatly depending upon the test procedure employed.
Full text
PDF
Selected References
These references are in PubMed. This may not be the complete list of references from this article.
- CORNE S. J., PICKERING R. W., WARNER B. T. A method for assessing the effects of drugs on the central actions of 5-hydroxytryptamine. Br J Pharmacol Chemother. 1963 Feb;20:106–120. doi: 10.1111/j.1476-5381.1963.tb01302.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- DOEPFNER W., CERLETTI A. Comparison of lysergic acid derivatives and antihistamines as inhibitors of the edema provoked in the rat's paw by serotonin. Int Arch Allergy Appl Immunol. 1958;12(1-2):89–97. doi: 10.1159/000228445. [DOI] [PubMed] [Google Scholar]
- Ferrini R., Glässer A. Antagonism of central effects of tryptamine and 5-hydroxytryptophan by 1,6-dimethyl-8beta-carbobenzyloxy-aminomethyl-10alpha-ergoline. Interference with amphetamine and DOPA. Psychopharmacologia. 1965 Nov 16;8(4):271–276. doi: 10.1007/BF00407859. [DOI] [PubMed] [Google Scholar]
- GADDUM J. H., PICARELLI Z. P. Two kinds of tryptamine receptor. Br J Pharmacol Chemother. 1957 Sep;12(3):323–328. doi: 10.1111/j.1476-5381.1957.tb00142.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
- Mawson C., Whittington H. Evaluation of the peripheral and central antagonistic activities against 5-hydroxytryptamine of some new agents. Br J Pharmacol. 1970 May;39(1):223P–224P. [PMC free article] [PubMed] [Google Scholar]
- RUBIN B., PIALA J. J., BURKE J. C., CRAVER B. N. A NEW, POTENT AND SPECIFIC SEROTONIN INHIBITOR, (SQ 10,643) 2'-(3-DIMETHYLAMINOPROPYLTHIO) CINNAMANILIDE HYDROCHLORIDE: ANTISEROTONIN ACTIVITY ON UTERUS AND ON GASTROINTESTINAL, VASCULAR, AND RESPIRATORY SYSTEMS OF ANIMALS. Arch Int Pharmacodyn Ther. 1964 Nov 1;152:132–143. [PubMed] [Google Scholar]
- TEDESCHI D. H., TEDESCHI R. E., FELLOWS E. J. The effects of tryptamine on the central nervous system, including a pharmacological procedure for the evaluation of iproniazidlike drugs. J Pharmacol Exp Ther. 1959 Jul;126(3):223–232. [PubMed] [Google Scholar]
- Vogt M. Cerebral tryptamine receptors: functional considerations. Adv Pharmacol. 1968;6(Pt B):19–25. doi: 10.1016/s1054-3589(08)60291-4. [DOI] [PubMed] [Google Scholar]